# A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants

> **NCT05483998** · PHASE1 · COMPLETED · sponsor: **OrsoBio, Inc** · enrollment: 100 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** TLC-2716
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05483998
- **Lead sponsor:** OrsoBio, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-09
- **Primary completion:** 2023-04-13
- **Final completion:** 2023-06-18
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05483998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05483998, "A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05483998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*